terazosin

Generic: terazosin hydrochloride

Labeler: avpak
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler avpak
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 5 mg/1

Manufacturer
AvPAK

Identifiers & Regulatory

Product NDC 50268-766
Product ID 50268-766_38f32e51-5ff7-7191-e063-6294a90ae02b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2020-02-13

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50268766
Hyphenated Format 50268-766

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 50 BLISTER PACK in 1 BOX (50268-766-15) / 1 CAPSULE in 1 BLISTER PACK (50268-766-11)
source: ndc

Packages (1)

50268-766-15 50 BLISTER PACK in 1 BOX (50268-766-15) / 1 CAPSULE in 1 BLISTER PACK (50268-766-11)

Ingredients (1)

terazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "38f32e51-5ff7-7191-e063-6294a90ae02b", "openfda": {"unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["9e7b27a6-cc09-407e-e053-2a95a90a17b3"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 BOX (50268-766-15)  / 1 CAPSULE in 1 BLISTER PACK (50268-766-11)", "package_ndc": "50268-766-15", "marketing_start_date": "20200213"}], "brand_name": "Terazosin", "product_id": "50268-766_38f32e51-5ff7-7191-e063-6294a90ae02b", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "50268-766", "generic_name": "Terazosin Hydrochloride", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20200213", "listing_expiration_date": "20261231"}